Physician profile
Tan Tran
NPI 1508807066
$3,297.82
in general payments reported to CMS, 2019-2025
7 companies · $331 in 2025
The $331 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $512 · 2020: $577 · 2021: $766 · 2022: $384 · 2023: $451 · 2024: $278 · 2025: $331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,059.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,059.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $3,014.20 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $70.15 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $61.56 | 2024 | Iqirvo |
| Abbvie INC. | $58.43 | 2024-2025 | |
| Allergan, INC. | $51.35 | 2019 | |
| Novo Nordisk INC | $27.08 | 2025 | Wegovy |
| Cumberland Pharmaceuticals, INC. | $15.05 | 2023 | Kristalose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tan Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.